Pharma Commerce editor takes a look back at 2023’s impressionable editorial content.
A Year in Review
Related Posts
Driving Adherence and Safety Through Digital Innovation
Patient safety and medication adherence are some of the major concerns in the pharmaceutical industry. With an increase in medication…
The Rise of GLP-1 Drugs and the Challenges of Proper Disposal
The emergence of glucagon-like peptide-1 (GLP-1) drugs such as liraglutide (Saxenda), semaglutide (Ozempic, Wegovy), and tirzepatide (Mounjaro, Zepbound) has transformed…
Overcoming Bottlenecks in Personalized Medicine Manufacturing
In a video interview with Pharma Commerce, Jason C. Foster, CEO of Ori Biotech, describes how the current state of…